JFG
COLL icon

Jefferies Financial Group’s Collegium Pharmaceutical COLL Stock Holding History

Jefferies Financial Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-41,500
Closed -$963K – 1680
2022
Q4 		$963K Buy
+41,500
New +$837K 0.01% 881

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Jefferies Financial Group's COLL Position: Q2 2026 in Review

Jefferies Financial Group increased its Collegium Pharmaceutical (COLL) stake by 13% in Q2 2026, buying an estimated $106K and bringing the position to 27,400 shares worth $992K. The position accounts for 0.01% of the portfolio, ranked #973.

Jefferies Financial Group first reported a position in COLL in Q1 2017 and has held it in 9 quarters since. The position peaked at $11.3M in Q2 2024. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Jefferies Financial Group held 27,400 shares of Collegium Pharmaceutical worth $992K as of Q2 2026.
  • Jefferies Financial Group bought 3,100 Collegium Pharmaceutical shares in Q2 2026, an estimated $106K.
  • Collegium Pharmaceutical made up 0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #973 holding.
  • Jefferies Financial Group first reported a position in Collegium Pharmaceutical in Q1 2017 and has held it in 9 quarters since.
  • Jefferies Financial Group's Collegium Pharmaceutical position peaked at $11.3M in Q2 2024.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.